Seoul, Korea — 19–20 June 2026 — Genèse Labs took part in AMWC Korea 2026 in Seoul, presenting its full portfolio — including NADX³ and AxeniQ™, launched in March — to Korea’s aesthetic-medicine specialists. Over both days, the booth was consistently crowded with practitioners seeking consultations.

• Participation in the Korean edition of the global AMWC series

• First congress presentation of NADX³ and AxeniQ™ since their March launch

• In Korea’s PDLLA-driven market, enquiries centred on Proluma™ PDLLA and KFDA-approved Réluma

• A successful show, with consultations running continuously over both days

AMWC Korea carries the scientific philosophy of the Monaco congress into a Korean edition, bringing together the country’s aesthetic-medicine specialists around the latest clinical evidence and techniques. Where KIMES offered broad partner reach, AMWC Korea provided a setting for deeper scientific exchange with practitioners.

Korea is a market where PDLLA-based collagen boosters have become mainstream, and Proluma™ PDLLA — with its smooth handling and natural results — drew a particularly high number of consultations. KFDA-approved Réluma also attracted steady interest, and the team heard positive feedback first-hand from practitioners who had begun using NADX³ since its March launch.

Across both days, practitioners streamed to the booth between scientific sessions to see the products for themselves. Following KIMES in March, AMWC Korea further consolidated Genèse Labs’ position in Korea in the first half of 2026.

Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across body contouring, collagen biostimulation, fillers, neuromodulators, and longevity and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including the RG Body Filler line, Proluma™ (PDLLA, PLLA and RH Collagen), Réluma, SofistiCa, AxeniQ™, NADX³, Aqua Feel, MESO PEPTA™, Citrus Bottle™, Exoluma™ (Human, Plant and Exo-PDRN) and Exo-Mask — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.